Zeroing out 'Writing' Time for Pharmaceutical QA|AI SaaS from UTokyo Matsuo Lab's EQUES Supports Automatic Generation of Deviation Reports and Annual Reviews, Realizing DX in Quality Management
NQ Score
50/100
AI Summary (NQ-processed)
EQUES Updates QA Operations Efficiency AI SaaS 'QAI Generator'.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is the name of the AI SaaS released by EQUES Co., Ltd. for streamlining pharmaceutical QA documentation?
- A: The AI SaaS released by EQUES Co., Ltd. for streamlining documentation is named "QAI Generator".
- Q: Who is the Representative Director of EQUES Co., Ltd. mentioned in the article?
- A: The Representative Director of EQUES Co., Ltd. is Naoki Kishi, according to the article.
- Q: Which new automatic generation functions have been added to QAI Generator in this release?
- A: This release adds automatic generation functions for Deviation Reports, Quality Information Reports, and Annual Reviews.
- Q: What was the first document type supported by the AI automatic generation function in the initial phase of QAI Generator?
- A: In the first phase of QAI Generator, EQUES provided an AI automatic generation function for change request forms.
- Q: What university lab is EQUES Co., Ltd., the developer of QAI Generator, originating from?
- A: EQUES Co., Ltd. is a startup that originates from the University of Tokyo Matsuo Lab (UTokyo Matsuo Lab).